Brigid Makes
CIK 1375927 · Chief Financial Officer · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$60.0K
Companies
7
Total Filings
35
Lifetime Open-Market Net
$35.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 27,000 | $0.92 | $24.7K | $13.0K | 4 | 2026-06-15 |
| QSI | Director | 20,512 | $0.76 | $15.6K | $0 | 6 | 2026-05-20 |
| VANI | Chief Financial Officer | 15,000 | $1.31 | $19.6K | $14.9K | 9 | 2025-05-14 |
| ELUTIA INC. (AZYO) Delisted | Director | 2,000 | $1.49 | $3.0K | $7.3K | 5 | 2023-06-12 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 10,580 | $15.00 | $158.7K | $0 | 3 | 2022-06-06 |
| AGA Medical Holdings, Inc. (AGAM) Delisted | CFO | 0 | — | — | $0 | 2 | 2010-11-18 |
| BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Director | 26,000 | — | — | $0 | 4 | 2008-06-16 |
Recent Filings · Page 3 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-06 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +64,656 | $0 | EDGAR |
| 2022-06-03 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +64,656 | $0 | EDGAR |
| 2022-05-24 | Definium Therapeutics, Inc. (MNMD) Delisted | Other (J) | +67,678 | $0 | EDGAR |
| 2022-05-13 | QSI | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | QSI | Grant (A) | +20,512 | $0 | EDGAR |
| 2021-06-09 | ELUTIA INC. (AZYO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-10 | ELUTIA INC. (AZYO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-18 | AGA Medical Holdings, Inc. (AGAM) Delisted | Mixed | −300 | -$6.2K | EDGAR |
| 2010-07-15 | AGA Medical Holdings, Inc. (AGAM) Delisted | — | — | $0 | EDGAR |
| 2009-06-09 | — | Exer (M) | +21,000 | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.